| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.02B | 28.92B | 32.70B | 31.35B | 38.75B | 27.14B |
| Gross Profit | 7.11B | 7.90B | 12.79B | 9.03B | 14.87B | 9.82B |
| EBITDA | 5.89B | 6.44B | 12.76B | 8.45B | 13.46B | 9.59B |
| Net Income | 2.65B | 2.81B | 3.42B | 2.31B | 3.75B | 2.22B |
Balance Sheet | ||||||
| Total Assets | 165.57B | 168.51B | 179.31B | 193.93B | 207.71B | 194.88B |
| Cash, Cash Equivalents and Short-Term Investments | 27.32B | 26.85B | 27.85B | 31.16B | 39.23B | 29.94B |
| Total Debt | 58.75B | 59.77B | 58.83B | 58.94B | 65.08B | 57.93B |
| Total Liabilities | 85.24B | 90.22B | 101.85B | 117.14B | 126.35B | 112.81B |
| Stockholders Equity | 49.16B | 47.57B | 46.60B | 45.52B | 47.44B | 43.68B |
Cash Flow | ||||||
| Free Cash Flow | 177.23M | 304.68M | 3.03B | -2.09B | 936.19M | 1.53B |
| Operating Cash Flow | 4.08B | 4.81B | 4.35B | -1.53B | 7.93B | 4.54B |
| Investing Cash Flow | -121.67M | -6.92B | -4.04B | -3.07B | -2.58B | -4.89B |
| Financing Cash Flow | -5.21B | -1.38B | -3.34B | -4.56B | 2.91B | -3.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$22.46B | 5.68 | 6.18% | 5.00% | 7.45% | 11.56% | |
71 Outperform | HK$15.85B | 5.98 | 5.58% | 6.37% | -7.44% | -18.48% | |
69 Neutral | HK$31.74B | 11.60 | 4.43% | 5.88% | 6.95% | 24.07% | |
66 Neutral | HK$40.66B | 7.00 | 6.26% | 4.94% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
46 Neutral | HK$1.25B | -3.89 | -3.32% | 3.80% | 10.38% | 7.39% | |
42 Neutral | HK$35.60B | -7.53 | -3.65% | 0.44% | -8.93% | -698.78% |
Shanghai Industrial Holdings has renewed key lease arrangements for its tobacco operations in Hong Kong, with Nanyang Tobacco and the parent company entering new one‑year tenancy agreements for 2026 covering their major office and factory site in Tuen Mun. The Tuen Mun property, a 16‑storey building with a gross floor area of about 423,244 square feet, will continue to be leased from connected party Nanyang Enterprises at a monthly rent of HK$2.75 million, with terms set on an arm’s‑length basis and benchmarked against an independent valuation, ensuring continuity of operations while falling under the Stock Exchange’s continuing connected transaction regime that requires disclosure and annual review but no independent shareholders’ approval.
The most recent analyst rating on (HK:0363) stock is a Buy with a HK$16.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings has announced the completion of an internal reorganisation under which Golden Bell has been registered as the owner of all issued shares of SIIC, the company’s immediate controlling shareholder. As a result, Golden Bell now indirectly holds approximately 63.16% of Shanghai Industrial Holdings, 70.44% of Shanghai Industrial Urban Development Group and 50.12% of SIIC Environment, but the voting rights and ultimate control remain with the Shanghai Government, meaning there is no effective change of control in these listed entities. The Hong Kong Takeovers Executive has granted SIIC Shanghai and Golden Bell a waiver from the obligation to make a general offer for the shares of Shanghai Industrial Holdings, SIUD, SIIC Environment and Shanghai Pharmaceuticals following the reorganisation, and the company has cautioned shareholders and investors to exercise care when dealing in its securities.
The most recent analyst rating on (HK:0363) stock is a Buy with a HK$16.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings, through its indirect subsidiary SIUD Shanghai Healthcare Management, has entered into an agreement to sell its 19% equity interest in a target company to Shanghai Lingfeng Medical for RMB73,598,000. This transaction will result in Shanghai Lingfeng Medical becoming the sole owner of the target company, which will no longer be an associate of Shanghai Industrial Holdings. The disposal is classified as a connected transaction under the Hong Kong Listing Rules due to the relationships between the involved parties, but it is exempt from the circular and independent shareholders’ approval requirements.
The most recent analyst rating on (HK:0363) stock is a Hold with a HK$15.00 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings, through its subsidiary Wing Fat Printing, has entered into a Procurement Framework Agreement with Shanghai Pharmaceuticals Holding. This agreement, effective from January 1, 2026, to December 31, 2026, allows Wing Fat Group to supply printed packaging materials for pharmaceutical products to Shanghai Pharmaceuticals Holding Group, subject to an annual procurement cap. The agreement is classified as a continuing connected transaction under Hong Kong’s Listing Rules, requiring only reporting, announcement, and annual review due to its size. This strategic move aligns with the company’s efforts to strengthen its market position in the pharmaceutical packaging sector.
The most recent analyst rating on (HK:0363) stock is a Hold with a HK$15.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.
Shanghai Industrial Holdings, a company indirectly controlled by the Shanghai Government, has announced a proposed internal reorganization. The reorganization involves changing the registered owner of its immediate controlling shareholder, SIIC, to Golden Bell. Despite this change, the ultimate control of the company remains with the Shanghai Government, as all entities involved are wholly owned by it. This announcement is made voluntarily, and stakeholders are advised to exercise caution when dealing with the company’s securities.
The most recent analyst rating on (HK:0363) stock is a Hold with a HK$15.50 price target. To see the full list of analyst forecasts on Shanghai Industrial Holdings stock, see the HK:0363 Stock Forecast page.